OBJECT: The objective of this study was to characterize the clinical features of radiation-induced cavernous malformations (RICMs). METHODS: The authors retrospectively reviewed the clinical and radiological characteristics of patients with RICMs. The features of these RICMs were then compared with features of nonradiation cavernous malformations (CMs) in 270 patients. RESULTS: Thirty-two patients with RICMs were identified (56.2% men), with a median age of 31.1 years at RICM diagnosis. The median latency from radiation treatment to RICM diagnosis was 12.0 years (interquartile range 5.0-19.6 years). RICMs were always within the previous radiation port. RICMs were symptomatic at diagnosis in 46.9%, and were associated with symptomatic intracranial hemorrhage at any time in 43.8%. Older age at the time of radiation treatment and higher radiation dose were associated with shorter latency. RICMs tended to be diagnosed at a younger age than nonradiation CMs (median 31.1 vs 42.4 years, respectively; p = 0.054) but were significantly less likely to be symptomatic at the time of diagnosis (46.9% vs 65.8%, respectively; p = 0.036). RICMs were more likely to be multiple CMs than nonradiation CMs (p = 0.0002). Prospectively, the risk of symptomatic hemorrhage was 4.2% for RICMs and 2.3% for nonradiation CMs per person-year (p = 0.556). In the absence of symptoms at presentation, the risk of hemorrhage for RICMs was higher than for nonradiation CMs (4.2% vs 0.35%, respectively; p = 0.118). CONCLUSIONS: In this patient population, RICMs occurred within the radiation port approximately 12 years after radiation treatment. Compared with nonradiation CMs, RICMs were more likely to occur as multiple CMs, to present at a younger age, and were at least as likely to cause symptomatic hemorrhage.
OBJECT: The objective of this study was to characterize the clinical features of radiation-induced cavernous malformations (RICMs). METHODS: The authors retrospectively reviewed the clinical and radiological characteristics of patients with RICMs. The features of these RICMs were then compared with features of nonradiation cavernous malformations (CMs) in 270 patients. RESULTS: Thirty-two patients with RICMs were identified (56.2% men), with a median age of 31.1 years at RICM diagnosis. The median latency from radiation treatment to RICM diagnosis was 12.0 years (interquartile range 5.0-19.6 years). RICMs were always within the previous radiation port. RICMs were symptomatic at diagnosis in 46.9%, and were associated with symptomatic intracranial hemorrhage at any time in 43.8%. Older age at the time of radiation treatment and higher radiation dose were associated with shorter latency. RICMs tended to be diagnosed at a younger age than nonradiation CMs (median 31.1 vs 42.4 years, respectively; p = 0.054) but were significantly less likely to be symptomatic at the time of diagnosis (46.9% vs 65.8%, respectively; p = 0.036). RICMs were more likely to be multiple CMs than nonradiation CMs (p = 0.0002). Prospectively, the risk of symptomatic hemorrhage was 4.2% for RICMs and 2.3% for nonradiation CMs per person-year (p = 0.556). In the absence of symptoms at presentation, the risk of hemorrhage for RICMs was higher than for nonradiation CMs (4.2% vs 0.35%, respectively; p = 0.118). CONCLUSIONS: In this patient population, RICMs occurred within the radiation port approximately 12 years after radiation treatment. Compared with nonradiation CMs, RICMs were more likely to occur as multiple CMs, to present at a younger age, and were at least as likely to cause symptomatic hemorrhage.
Authors: Alexandra Russo; Marie Astrid Neu; Johanna Theruvath; Bettina Kron; Arthur Wingerter; Silla Hey-Koch; Yasemin Tanyildizi; Joerg Faber Journal: Childs Nerv Syst Date: 2017-05-09 Impact factor: 1.475
Authors: Rachel N Andrews; Ethan G Bloomer; John D Olson; David B Hanbury; Gregory O Dugan; Christopher T Whitlow; J Mark Cline Journal: Radiat Res Date: 2020-09-16 Impact factor: 2.841
Authors: Seán B Lyne; Romuald Girard; Janne Koskimäki; Hussein A Zeineddine; Dongdong Zhang; Ying Cao; Yan Li; Agnieszka Stadnik; Thomas Moore; Rhonda Lightle; Changbin Shi; Robert Shenkar; Julián Carrión-Penagos; Sean P Polster; Sharbel Romanos; Amy Akers; Miguel Lopez-Ramirez; Kevin J Whitehead; Mark L Kahn; Mark H Ginsberg; Douglas A Marchuk; Issam A Awad Journal: JCI Insight Date: 2019-06-20
Authors: Atif Zafar; Brian Fiani; Hamid Hadi; Mohammad Arshad; Alessandra Cathel; Muhammad Naeem; Matthew S Parsons; Mudassir Farooqui; Abigail A Bucklin; Michael J Leone; Aqsa Baig; Syed A Quadri Journal: Neurol Sci Date: 2020-04-25 Impact factor: 3.307